BMC pregnancy and childbirth · 2026
Cervical human papillomavirus positivity in hydatidiform mole and spontaneous miscarriage: a retrospective case-control study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Vural Nazli Aylin, Ertok Çisem, Tokaç Candan Gül, Güner Gazi, Satilmişoğlu Zeliha Zeynep, Arslan Hilal Serap, Yüksel İlkbal Temel
Аннотация
INTRODUCTION: Human papillomavirus (HPV) has been associated with several adverse pregnancy outcomes, but its relationship with hydatidiform mole remains unclear. The aim of this study was to compare cervical HPV positivity between patients with hydatidiform mole and spontaneous miscarriage.
MATERIALS AND METHODS: A retrospective case-control study was conducted at a tertiary gynecologic oncology center between May 2020 and June 2024. Patients who underwent dilatation and curettage included those with hydatidiform mole (n = 55) and spontaneous miscarriage (n = 109). Demographic and clinical characteristics, including age, parity, chronic disease, and cervical HPV status and genotypes, were collected. Chi-square test was used to assess the association between diagnosis and HPV status.
RESULTS: Cervical HPV positivity was observed in 5 (9.1%) patients with hydatidiform mole and 10 (9.2%) with spontaneous miscarriage (p = 0.986). All HPV-positive molar pregnancy cases were identified within the partial hydatidiform mole.
CONCLUSION: Cervical HPV positivity did not differ significantly between hydatidiform mole and spontaneous miscarriage. HPV positivity was observed only in partial mole cases in our cohort; however, the number of HPV positive mole cases was small, and this finding should be considered descriptive only. These findings do not show whether HPV was present in molar tissue.
MATERIALS AND METHODS: A retrospective case-control study was conducted at a tertiary gynecologic oncology center between May 2020 and June 2024. Patients who underwent dilatation and curettage included those with hydatidiform mole (n = 55) and spontaneous miscarriage (n = 109). Demographic and clinical characteristics, including age, parity, chronic disease, and cervical HPV status and genotypes, were collected. Chi-square test was used to assess the association between diagnosis and HPV status.
RESULTS: Cervical HPV positivity was observed in 5 (9.1%) patients with hydatidiform mole and 10 (9.2%) with spontaneous miscarriage (p = 0.986). All HPV-positive molar pregnancy cases were identified within the partial hydatidiform mole.
CONCLUSION: Cervical HPV positivity did not differ significantly between hydatidiform mole and spontaneous miscarriage. HPV positivity was observed only in partial mole cases in our cohort; however, the number of HPV positive mole cases was small, and this finding should be considered descriptive only. These findings do not show whether HPV was present in molar tissue.